Right-to-Try and Expanded Access to Experimental Drugs Checklist

Summary

This checklist addresses best practices for advising drug companies about complying with right-to-try and expanded access provisions of the 21st Century Cures Act, 114 Pub. L. 255, and the Right to Try Act of 2018, Pub. L. 115–176 (RTTA). This checklist addresses federal law and does not cover all potential state and local law distinctions.